Mitogen-activated protein kinases (MAPK) signaling affects many processes, some of which 3 have different outcomes in the same cell. In Arabidopsis, activation of a MAPK cascade consisting of 4 YODA, MKK4/5 and MPK3/6 inhibits early stages of stomatal developmental, but this ability is lost at 5 the latest stage when guard mother cells (GMCs) transition to guard cells (GCs). Rather than 6 downregulating cascade components, stomatal precursors must have a mechanism to prevent late stage 7 inhibition because the same MKKs and MPKs mediate other physiological responses. Here, we 8 artificially activated the MAPK cascade using MKK7, another MKK that can modulate stomatal 9 development, and found that inhibition of stomatal development is still possible in GMCs. This suggests 10 that MKK4/5, but not MKK7, are specifically prevented from inhibiting stomatal development. To 11 identify regions of MKKs responsible for cell-type specific regulation, we used a domain swap approach 12 with MKK7 and a battery of in vitro and in vivo kinase assays. We found that N-terminal regions of 13 MKK5 and MKK7 establish specific signal-to-output connections like they do in other organisms, but 14 they do so in combination with previously undescribed modules in the C-terminus. One of these modules 15 encodes the GMC-specific regulation of MKK5, that when swapped with MKK7's, allows MKK5 to 16 mediate robust inhibition of late stomatal development. Because MKK structure is conserved across 17 species, the identification of new MKK specificity modules and signaling rules furthers our understanding 18 of how eukaryotes create specificity in complex biological systems. 19 20 21 an unidentified MPK. (C-F) Tracings of phenotypes resulting from activation of kinases. In C-D, 72 constitutively active MKK5 (MKK5 DD ) or MKK7 (MKK7 ED ) inhibit initiation (division of meristemoid 73 mother cell (MMC) into meristemoid (M)) and lineage progression (conversion of M into guard mother 74 cell (GMC)). In E-F, MKK5 DD has no effect (E, WT numbers and distribution of stomata in green), but 75 MKK7 ED induces guard cell (GC) overproliferation and clustering (F). Stages are referred to as SPCH, 76 MUTE and FAMA after the promoters to drive expression of MAPK network components (Lampard et 77 al., 2009). YDA, YODA; 5, MKK5; 7, MKK7; 3/6, MPK3 and MPK6. 93 94 95 Materials and Methods 96 97 Plant material and growth conditions 98 All transgenic lines were generated in the Col-0 background. Seeds were plated on 0.5X 99 Murashige-Skoog media containing 1% agar-agar (Caisson Laboratories, North Logan, UT) and 100 100 µg/ml Kanamycin (Sigma-Aldrich) or 50 m/ml Hygromycin B (Life Technologies) when appropriate. 101 Seedlings were grown under a light intensity of 100 μmol photons m -2 s -1 in a 16:8 photoperiod at 22 ± 102 1ºC. Analyses were performed in 15 day after germination (dag) cotyledons unless stated otherwise. The 46: 331-342. 629 Chen, R.E. and Thorner, J. (2007). Function and regulation in MAPK signaling pathways: Lessons 630 learned from the yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta -Mol. Cell Res. 1773: 631 . Conservation, variability and the 658 modeling of active protein kinases. PLoS One 2.
Introduction 22
MAPKs have strategic roles in signal processing, in mediating stress responses, and in guiding 23 cell fate transitions and development (Keshet and Seger, 2010; Rodriguez et al., 2010; Yang et al., 2013; 24 Chen and Thorner, 2007) . MAPK networks consist of a three-tiered cascade whose kinases--MAPK 25 kinase kinase or MKKK, MAPK kinase (Mapk/Erk kinases or MEK in animals, MKK in Arabidopsis) and MAPK (MPK in Arabidopsis) sequentially phosphorylate and activate each other upon signal 27 perception. Downstream effectors may respond to MPK-mediated phosphorylation by changes in protein 28 activity, localization or stability, and many of these alterations ultimately alter transcriptional programs. 29
The MKK level is a bottleneck in many species. In humans, at least 25 MKKKs activate the 7 MEKs, 30 which lie upstream of 14 MAPKs (Keshet and Seger, 2010). In Arabidopsis thaliana, more than 60 31
MKKKs are predicted upstream of 10 MKKs and 23 MPKs (Dóczi et al., 2012) . Evidence exists that 32
MKKs can activate more than one MPK, and a given MPK may have more than one upstream MKK 33 (Andreasson and Ellis, 2010) . Intuitively, this arrangement could facilitate signal integration, as multiple 34 signals could converge on a single effector. The use of common components, however, could also lead to 35 erroneous cross-activation. 36
When expressing multiple MAPK network components and responding to multiple sources of 37 information, how do cells generate an appropriate output to a particular signal? One strategy is to make 38 downstream effectors available in only certain cells (Lampard et al., 2008) In Arabidopsis, MAPK signaling has been shown to have a fundamental role in the formation of 50 stomata, the structures in the epidermis of plants that regulate gas exchange (Bergmann et al., 2004 ; 51 stomatal precursors have mechanisms to limit certain cellular outputs and generate MKK-specific 53 responses (Lampard et al., 2009 (Lampard et al., , 2014 . Only four of the 10 MKKs -MKK4, MKK5, MKK7 and MKK9-54 have any capacity to influence stomatal development during lineage initiation, guard mother cell (GMC) 55 commitment and/or guard cell (GC) formation (for simplicity, only MKK5 and MKK7 are shown in 56 MKK4 and MKK5 indicate that these kinases are endogenously required to limit stomatal production 61 (Wang et al., 2007) , but the MKK7/9 significance is unclear as mkk9 single mutants do not affect stomata 62 and in the recent report of true loss of function mutations in mkk7 mutants no stomata phenotype was 63 described (Jia et al., 2016) . Rewiring of MAPK cascades in Arabidopsis 6 79 MKK4/5's endogenous role in limiting stomatal production in early stages, but not in late 80 stomatal lineage cells, provides an excellent test case for examining how cell identity may interface with 81 signaling response. We created a quantitative phenotypic analysis pipeline that revealed a previously 82 underappreciated capacity for late stage stomatal lineage cells to be inhibited by MAPK signaling. Then, 83 taking advantage of divergent responses to constitutively activated MKK5 and MKK7, we implemented a 84 protein engineering approach to identify structural domains in MKK5 that are responsible for its stage-85 specific behaviors. We found that MKK N-terminal regions establish specific signal-to-output 86 connections, much like they do in other organisms (Won et al., 2011) , but this requires coordination with 87 previously unexplored regions in the C-terminus. We also found that a minimal domain in the C-terminus 88 encodes the basis for MKK-specific regulation. The location of specificity modules within the plant 89 proteins corresponds to regions in which their human homologues display high sequence diversity, 90 suggesting that these regions may contribute to specificity in many situations. Given the global 91 conservation of MAPK signaling, our findings in the complex multicellular context of plant development 92 may offer insights into general mechanisms of signaling specificity in complex biological systems. mpk6-3 allele was Salk_127507 (Müller et al., 2010) . Mutant alleles for EDR1 (Salk_127158), MAP3K1 104 (Salk_048985) and MAP3K5 (Salk_029929 and Salk_036615) were obtained from the ABRC. 105 106
Multiple sequence alignment and structural analysis 107
Selected mammalian kinases were aligned using ClustalOmega (Sievers et al., 2011) and 108 structural models are in Supplemental Figure 3B . MKK5 and MKK7 structural predictions were 109 performed with I-Tasser (Zhang, 2008), using MEK1 (1S9J) to assist the prediction. Models were 110 explored with Swiss-PdbViewer v4.1 and fit with the Magic Fit button (Guex and Peitsch, 1997 
Construction of constitutively active MKK and synthetic chimeras 115
Domain swap constructs were assembled by fusion PCR from DNA amplicons (blocks) generated 116 with Phusion® High-Fidelity DNA Polymerase following manufacturer's instructions (New England  117 Biolabs, Ipswich, MA). To generate blocks, MKK5 DD and MKK7 ED cloned into pENTR without stop 118 codons or other chimeras were used as templates (Lampard et al., 2009 ). Blocks were designed to contain 119 attL1 and attL2 functional sequences from pENTR to ease the cloning procedure through the Gateway 120 strategy (Supplemental File 1). For domain swaps assembled from two blocks, 5' blocks contained the 121 M13 forward priming site and attL1 recombination site before the MKK sequence; and 3' blocks 122 contained the MKK sequence followed by attL2 recombination site and M13 reverse priming site. To 123 facilitate fusion of the blocks, reverse primers for 5' blocks and forward primers for 3' blocks were 124 designed as chimeras of the two blocks to be fused, containing at least 15 bases from each block, and 125
were completely complementary to each other. PCR products were gel extracted using QIAquick Gel 126 Extraction Kit (QIAGEN Inc., Valencia, CA) and 1:1 molar ratio mix were used as templates on fusion 127 cloned into pJET 1.2 according to CloneJET PCR Cloning Kit instructions (Thermo Life Sciences, 129 Pittsburgh, PA). For domain swap constructs assembled from 3 blocks, 5' and 3' were generated with the 130 same strategy as above, while internal block was amplified with forward and reverse chimeric primers. As 131 domain swaps became more elaborate, first domain swap constructs were used as templates for generating 132 new blocks. Primers, templates and sequences for each domain swap are listed in Supplemental Table 1 flanked by attR4 and attR2 recombination sites, in frame C-terminal fusion to enhanced YFP and 142 kanamycin selection in plants (Nakagawa et al., 2008) ]. Recombination reactions were performed in a 143 two-step protocol. First, 1 µl of LR Clonase II was added to 4 µl vector mix (containing 150 ng of 144 pDONR-promoter and 150 ng pJET-domain swap construct) and incubated at 25ºC for 5 hours. Then, 150 145 ng of R4pGWB440 in 4 µl solution were added to the reactions along 1 µl of LR Clonase II. Reactions 146 were incubated for additional 16 hours at 25ºC and then stopped after the addition of 1 µl of Proteinase K 147 and incubation for 10 min at 37ºC. Constructs were confirmed by sequencing and introduced in 148 Arabidopsis by Agrobacterium tumefaciens-mediated transformation. 149
Mutants edr1, map3k1 and map3k5 were transformed with FAMA pro :MKK5 DD in pHGY, 150 previously used in (Lampard et al., 2009 ). MPK3 and MPK6 clones were provided by Jean Colcombet 151 (INRA Versailles-Grignon, France) (Berriri et al., 2012) . 152
Seedlings (15 dag) were fixed in 7:1 ethanol:acetic acid, and cleared in Hoyer's medium. 155
Cotyledons were imaged by differential interference contrast microscopy on a Leica DM2500 microscope 156 at ×20 magnification (0.320 mm −2 field of view). One picture per independent transgenic seedling was 157 taken from the distal tip of the cotyledons, within the vascular loop, on the abaxial epidermis. Phenotypes 158 at the FAMA stage were as follows: (1) normal phenotype, only single stomata with tolerance for 1 159 stomatal cluster per field of view; (2) stomatal inhibition, no stomata present or inhibited precursors 160 coexisted with normal stomata and appeared in at least two independent fields of view per sample; (3) 161 large stomatal cluster, at least two stomatal clusters (4 or more stomata in contact) per field of view; (4) 162 small stomatal cluster, clusters contained 2-3 stomata in contact. When a sample contained a mixed 163 population of clusters, the presence of large clusters defined the classification for this category. MKK7 ED , 164 clusters were systematically bigger than any chimera and often were delayed in development; to confirm 165 clustering, older epidermis (near apical hydathode or in older plants) was scored. SPCH stage phenotypes 166 were quantified as (1) inhibited (no stomata per field of view) or (2) not inhibited (2 or more stomata per 167 field of view). To enable us to score phenotypes in T1 seedlings that must be grown on antibiotic 168 selection, we grew 35S:YFP lines with the same antibiotic resistance as the MKK variants under the same 169 conditions and scored these as the equivalent of WT controls. 170 A binomial distribution for phenotypic data was assumed and the percentages of each phenotype 171 were calculated with a confidence of 95%. This analysis is similar to others done on data of comparable 172 nature (Wang et al., 2011) . Linear regressions between in vitro and in vivo data; and between SPCH and 173 FAMA data in Figure 7 and Supplemental Figure 7 were done with Microsoft Excel. To cluster chimeras, 174 hierarchical clustering was performed on phenotypic data at the FAMA stage using the function pvclust in 175 the statistical software R. Percentages of each one of the four phenotypes -Inhibited, Normal, Small 176 Clusters and Large Clusters-were converted to frequencies (e.g. dividing by 100). The distance matrix 177 was obtained by calculating the dissimilarities between all chimeras in their four phenotypes with the 178 squared test of independence was implemented to compare phenotype distributions. Frequencies were 181 compared to YFP (inactive), MKK5 DD , MKK7 ED (inhibition of stomatal formation and stomatal clustering) 182 and N5-MKK7 ED (strong stomatal inhibition). Chimeras that were not statistically different are noted with 183 the same number in Figure 7B . Unnumbered chimeras were statistically different from the rest (p < 0.05). 184 185
Confocal microscopy 186
Confocal images were collected using a Leica SP5 confocal microscope with excitation/emission 187 spectra of 514/520 to 540 for YFP and 565/580 to 610 for propidium iodide counterstaining. ImageJ (NIH) 188 was used to build Z-stacks from confocal images. To improve resolution of cell outlines, layers were 189 summed rather than averaged. Z-stacks were then split into single channels and only the channel for the 
Kinase-inactive MPK3 and MPK6 phosphorylation 197
In vitro kinase assays to assess the ability of MKK variants to phosphorylate either kinase 198 inactive (KI) MPK3 or MPK6 were performed as described in (Lampard et al., 2014 
Yeast two-hybrid assays
Yeast two-hybrid assays was performed with the matchmaker Two-Hybrid System 3 (Clontech) 207 using a modified set of plasmids compatible with Gateway technology and conditions specified by the 208 manufacturer. MKKs and chimeras were cloned as DNA Binding Domain fusions and MPKs were cloned 209 as Activation Domain fusions. Three independent yeast colonies were tested for each pairwise 210 comparison at 1, 1:10 and 1:100 dilutions after incubation of 2, 3 and 4 days in plates containing 1 mM 3-211 amino-1/2/4-triazole. Experiments were repeated three times with yeast cultures at OD600 of 1, 2 and 4. 212
Interactions were evaluated as positive if significant growth was detected in 1:100 dilution at day 3. 
Stomatal development is inhibited by MAPK activation at the FAMA stage 224
To carefully define the range of phenotypes in our system, we re-analyzed the inhibitory effect of 225 CA-MKK expression in FAMA stage cells ( Figure 1B ) using more sensitive and quantitative 226 measurements than in our previous studies (Lampard et al., 2009 (Lampard et al., , 2014 . For simplicity, we selected one 227 representative MKK from each MKK4/5 and MKK7/9 pair as previous studies showed that MKK4 228 mirrors MKK5 activity, and MKK7 mirrors MKK9 activity, in every stage of stomatal development 229 (Lampard et al., 2009 (Lampard et al., , 2014 . Because MKKs were to be analyzed in planta, we selected MKK5 and 230 which are made dominantly active by replacing the regulatory S/T residues of the activation loop with 233 phosphomimetic D/E residues (MKK5 DD = MKK5 T215D,S221D and MKK7 ED = MKK7 S193E,S199D ) ( Previously, expression of MKK7 ED was shown to lead to stomatal hyperproliferation (Lampard et 254 al., 2009 ), and we could confirm that result: 54% T1s showed large stomatal clusters (Figure 2A and B, 255 Table 1) ; however, 26% were WT (most of which showed no YFP signal) and 20% had stomatal 256 precursors that failed to complete their development into GCs (Figure 2A and B, Inhibited) . This third 257 class died as seedlings. Among MKK5 DD -YFP transformants, there were no seedling lethals: 76% T1s 258 had a phenotype indistinguishable from controls ( Figure 2B , Table 1 ) and 24% exhibited one to three 259 small clusters (2-3 stomata in contact) per 0.32 mm 2. . Among control seedlings grown in parallel, ~8% 260 exhibited similar small clusters (Table 1) 2). MKK5, therefore appears to be subject to an additional level of in vivo regulation that blocks its 270 inhibitory effect, while MKK7 seems to escape this regulation. We reasoned that structural differences 271 between MKK5 and MKK7 could be probed to define the nature and the source of this differential 272 regulation. 273 274
Predicted tertiary structures of MKK5 and MKK7 suggest sources of MKK identity and specificity 275
We reasoned that the domains most likely to confer the FAMA-stage differential responses would 276 be surface exposed (thus available for interactions with partners) and would exhibit the greatest structural 277 and sequence divergence among MKKs. To facilitate the identification of such regions, we modeled plant Figure 3) . To assay the function of these domains, we measured the phenotypes induced by chimeras at 320 the FAMA stage in T1s and compared to those obtained for intact MKK5 DD and MKK7 ED . Expression 321 and subcellular localization of YFP-tagged MKKs was verified by confocal microscopy. We predicted 322 that certain domain combinations could result in non-functional chimeras. Because expression of 323 MKK5 DD and non-functional chimeras would give essentially the same phenotype at the FAMA stage (no 324 effect on stomatal development), it was important to discriminate MKK5 DD -like chimeras from non-325 functional chimeras. We took two approaches to verify that kinases were still active. First, we measured 326 the intrinsic kinase activity against MPK3/6 in in vitro kinase assays (Supplemental Figure 2) . Second, we 327 took advantage of the fact that both MKK5 DD and MKK7 ED drive robust inhibition of stomatal initiation at 328 the SPCH stage (Lampard et al., 2009) to create an in vivo assay for kinase activity. We expressed the 329 chimeras at the SPCH stage and quantified the degree of inhibition of stomatal initiation (Table 1) .
To characterize the role of the N-terminus in MKK5, we replaced it with the N-terminus of 331 MKK7 (N7-MKK5 DD ) and the chimera was expressed in FAMA stage cells. ~59% of T1 transformants 332 produced stomatal clusters ( Figure 4B and G), though clusters were smaller than those generated by 333 MKK7 ED . In addition, 9% of T1 transformants showed inhibition of stomatal formation ( Figure 4G ). We 334 also noticed that N7-MKK5 DD partially relocalized to mitochondria ( Figure 4B ) similar to MKK7 ED 335 (Lampard et al., 2014) . Our in vitro and in vivo controls for activity both indicated that N7-MKK5 DD was 336 less active than intact MKK5 DD ; only ~27% of T1s inhibited stomatal initiation ( Figure 4H ) and in vitro 337 kinase activity was lower, especially towards MPK3 ( Figure 4I ). This dramatic output alteration 338 (aphenotypic MKK5 DD to a weak MKK7 ED -like behavior) suggests that the N-terminus is more than just a 339 structural/regulatory region required for protein activity. Instead, it appears to channel the MKK towards 340 specific phenotypic outcomes. This specificity behavior resembles that observed in yeast where MKKs 341 involved in other cellular processes were engineered to interact with components of the mating pathway, Figure 4 ). Unlike MKK5 DD , N5-MKK7 ED completely inhibited GC production ( Figure 4C and 362 G). Thus, with this manipulation, we were finally able to recapitulate the stomatal lineage inhibition 363 phenotype we had expected from MKK5 DD based on its ability to inhibit stomatal development at earlier 364 stages (Lampard et al., 2009 ) and the loss of function stomatal cluster phenotype (Wang et al., 2007) . 365 366
Loop B prevents MKK5 DD from inhibiting stomata formation at the FAMA stage 367
Demonstrating that development of FAMA-stage cells could be inhibited, however, raised the 368 question of why intact MKK5 DD is unable to do so. We hypothesized that sequences in the MKK5 C-369 terminus act as negative regulatory regions. To test this idea, we first replaced the entire C-terminal 370 region of MKK5, creating MKK5 DD -C7. FAMA-stage expression did result in a partially penetrant 371 inhibition of stomatal formation where inhibited precursors coexisted with normal stomata ( Figure 4D  372 and G). MKK5 DD -C7 displayed high activity in SPCH-stage lineage inhibition ( Figure 4H ), but was less 373 efficient than MKK5 DD in in vitro kinase assays, particularly towards MPK3 ( Figure 4I ). Because 374 previously reported MKK5 deletions in the CDR portion of the C-terminus did not significantly change 375 MKK5 DD activities (Lampard et al., 2014), we reasoned that putative regulatory regions were located in 376 the CPR. 377
The largest sequence differences between C5 and C7 reside in loop A and B in the CPR. 378
Substitution of loop A (MKK5 DD -7A) resulted in a chimera that did not affect stomatal development at 379 the FAMA stage ( Figure 4E and G), but substitution of loop B (MKK5 DD -7B) led to inhibition of stomatal 380 formation at high frequency ( Figure 4F and G) . This result suggests that MKK5's loop B is a region that 381 blocks MKK5 from participating in stomatal inhibition at the FAMA stage. Interestingly, SPCH stage activity was markedly reduced for both chimeras ( Figure 4H ), but in vitro activities of MKK5 DD -7A and 383 MKK5 DD -7B were at least as high as that of MKK5 DD ( Figure 4I ). These observations suggest that 384 MKK5 DD -7A and MKK5 DD -7B are catalytically active kinases but cannot generate appropriate signals in 385 vivo. 386 387
Loop B is required for robust MKK7 ED activity 388
If there was truly a discrete domain of MKK5 that was subject to negative regulation, then 389
transferring it to MKK7 ED should dampen the stomatal clustering phenotype at the FAMA stage ( Figure  390 5A). We initially swapped the entire C-terminus, and the resulting MKK7 ED -C5 only produced normal 391 stomata, similarly to MKK5 DD (Figure 5B and G). This could suggest that C5 is able to block MKK7 392 inhibitory function at FAMA stage. However, monitoring other indicators of MKK activity (SPCH stage 393 lineage inhibition and in vitro phosphorylation of MPK3 and MPK6) suggested that C7 was essential for 394 overall activity ( Figure 5H and I). Thus this phenotype is the result of creating a generally inactive MKK7 395 chimera, more than an effect due to the presence of MKK5 regulatory sequences. Thus, we split C5 into 396 CDR5 and CPR5, and determined if we could restore MKK7 ED activity in vitro and in the SPCH stage. 397
Activity was restored in MKK7 ED -CDR5: this chimera completely inhibited lineage initiation at the SPCH 398 stage and was indistinguishable from MKK7 ED in in vitro kinase assays ( Figure 5H and I). Rather than 399 decreasing MKK7 ED function, however, MKK7 ED -CDR5 had a strikingly stronger inhibitory effect on 400 stomatal development at the FAMA stage than MKK7 ED (Figure 5C and G). In fact, it resembled the 401 strong phenotype produced by N5-MKK7 ED (Figure 4C ). This implies that CDR5, like N5, channels 402 MKK activity to inhibition of stomatal development. In contrast, MKK7 ED -CPR5 was largely inactive at 403 both SPCH and FAMA stages ( Figure 5D and G), and in in vitro phosphorylation assays against MPK3 404 and MPK6 ( Figure 5H From these results, it appears that the CPR region is important for MKK7 ED catalytic activity and thus we 420 created smaller domain swaps (loops A and B) to attempt to transfer negative regulatory sequences from 421 MKK5 into MKK7 ED without affecting kinase functionality. MKK7 ED -5A and MKK7 ED -5B were active 422 in vivo (inhibited lineage initiation at the SPCH stage, Figure 5H ) and in vitro (phosphorylated MPK3/6, 423 Figure 5I ), although to different degrees. At the FAMA stage, MKK7 ED -5A inhibited stomatal formation 424 to a greater extent than MKK7 ED (Figure 5E and G) . This behavior is similar to N5-MKK7 ED ( Figure 4C ) 425 and MKK7 ED -CDR5 ( Figure 5C ), suggesting that N5, loop 5A and CDR5 restrict MKK7 ED activity to 426 inhibition of stomatal development. In contrast, MKK7 ED -5B's ability to cause stomatal clustering and 427 inhibition of stomatal development at the FAMA stage was markedly reduced when compared to 428 MKK7 ED ( Figure 5G ). Because MKK7 ED -5B also showed reduced activities in other indicators of MKK 429 activity ( Figure H and I) , we concluded that the negative regulation of MKK5 DD is restricted to loop 5B 430 but cannot be transferred without affecting MKK7 ED catalytic activity. Nevertheless, the same results 431 highlight that loop 7B is required for robust MKK7 ED activity. 432
Our results show that the N-terminus, CPR region (loops A and B) and CDR region modulate 435 MKK activity. We showed that N7 and CPR7 are necessary for MKK7 ED -mediated GC clustering at the 436 FAMA stage, but when CDR5 is incorporated into MKK7 ED , GC production is inhibited. If our "wiring 437 diagram" for specificity is correct, then a chimera that contains the GC promoting domains from MKK7 438 but not the inhibitory CDR5 (i.e., N7-MKK5 DD -C7) should mimic MKK7 ED . Indeed, when we constructed 439 N7-MKK5 DD -C7, it resembled MKK7 ED both qualitatively and quantitatively ( Figure 6A and C) . 440
Likewise, N5-MKK7 ED -C5 should match MKK5 DD activities, and it does in planta (Figure 6B and C) . 441
Interestingly, robust rewiring in vivo ( Figure 6C and D) appears to be uncoupled from kinase activity in 442 vitro, as both rewired proteins were much less capable of phosphorylating MPK3 and MPK6 than 443 MKK5 DD and MKK7 ED ( Figure 6E ). One interpretation of these swaps is that specificity lies only outside 444 of the kinase domain. If this were true, then we should be able to generate a chimera that resembles N7-445 MKK5 DD -C7 and MKK7 ED using the kinase domain from another MKK. We selected the kinase domain 
Comprehensive analysis of chimeras reveals functions of MKK domains 463
We repeatedly observed that the ability of native and chimeric MKKs to phosphorylate their 464 targets in vitro does not predict their activities in vivo. In fact, when chimera data are considered together, 465 in vitro versus in vivo data have no statistical correlation (Supplemental Figure 7) . In contrast, when only 466 in vivo data were compared, activities in SPCH and FAMA stages were positively correlated ( Figure 7A) . 467
Interestingly, native and chimeric MKKs were distributed in two subpopulations. MKKs closer to the 468 regression line promoted stomatal clustering (red dots) or inhibited stomatal formation (black dots). 469
MKKs further from the regression line had no effect in stomatal development at the FAMA stage (blue 470 dots), but had a broad range of activities at the SPCH stage (shaded area in Figure 7A ). This behavior 471 might be reflecting the additional regulation that some of the MKKs showed at the FAMA stage. We reasoned that MKKs subject to the same regulation would share structural similarities. To test 485 this hypothesis and generate an overall picture of the relationship between MKK structural domains and 486 in vivo functions, we clustered 15 native and chimeric MKKs and controls according to their quantitative 487 phenotype data at the FAMA stage (clustering detailed in methods). Constructs robustly fell into three 488 clusters ( Figure 7B ): Cluster 1, no phenotypic effect; Cluster 2, induces stomatal proliferation; and 489
Cluster 3, inhibits stomatal formation (the presumed endogenous role for MKK5). Within clusters, 490 however, not all MKKs were identical. We performed sequential tests of independence to determine how 491 similar the distribution of phenotype frequencies was between chimeras in each cluster. Cluster 1 was 492 composed of MKKs similar to MKK5 DD (group 1) and MKKs similar to inactive YFP (group 2). Cluster 2 493 was statistically separated into weak MKK7 ED -like chimeras (group 3) and two MKKs that induced strong 494
clustering, yet were different from each other. Cluster 3 was statistically separated into strong inhibitors 495 of stomatal formation (group 4) and weak inhibitors (different from each other). 496
To summarize, when analyzing native and chimeric MKK structures across Clusters, we see that 497 loops A and B have discrete functions in selecting MKK-specific outputs and in kinase activity in vivo. 498
Loop A can be thought of as a "channel selector", that, together with N-terminus and CDR, selects 499 between the normal role of arresting stomatal progression and the artificial role of promoting stomatal 500 clustering. Loop B is a "volume control" with the 7B version increasing, and 5B decreasing, the 501 phenotypes specified by the other domains of the MKKs 502 503 MPK6 mediates GC inhibition, but like MKK5, is prevented from doing so at the FAMA stage. 504
Previous loss-and gain-of-function experiments placed MPK3 and MPK6 downstream of an 505 activated MKK4/5 homologue (NtMEK2), suppressing stomatal formation (Wang et al., 2007) in the 506 early stages of the stomatal lineage, but this assay could not address the potential for MPK3 and MPK6 to 507 mediate FAMA-stage activities. Our chimeras that drive stomatal inhibition at the FAMA-stage, however, 508 could be used to see whether either mediated such late stage inhibition. We used N5-MKK7 ED which, in 509 function mpk6-3 background, N5-MKK7 ED failed to promote complete inhibition in 19 independent T1s 511 ( Figure 8D ) indicating that MPK6 is likely downstream. This led us to the question of whether MPK6, 512 like MKK5 DD , would also be actively inhibited from effecting fate at the FAMA stage. To test this, we 513 created a constitutively active MPK6 (MPK6 DE ) (Berriri et al., 2012) and tested its ability to suppress 514 stomatal formation. Expression of MPK6 DE (but not MPK3 DE , Figure 8A , Table 1 ), inhibited stomatal 515 progression at the SPCH stage, indicating that MPK6 DE is active in this assay. When expressed at the 516 FAMA stage, however, MPK6 DE did not affect stomatal development ( Figure 8B, Table 1 ), a phenotypic 517 output remarkably similar to that of MKK5 DD (early, but not late, inhibition). We hypothesized that 518 MKK5 and MPK6 normally repress stomatal development, but are actively prevented from having this 519 effect at the FAMA stage. 520 In multicellular organisms, coordinated development requires constant communication between 531 cells and the evaluation of environmental conditions. All this information is integrated to decide from a 532 spectrum of possible outputs, and the spectrum is frequently limited by a cell's identity. In previous, more 533 superficial studies, FAMA stage cells appeared to lose the ability to inhibit stomatal development upon 534 this cellular outcome. Structural analysis and engineered chimeras revealed that this regulation and other 537 specific responses rely on distinct MKK domains. 538
We found that Arabidopsis MKKs behave as modular proteins with four discrete regions: N-539 terminus, CDR and two loops (A and B) in the CPR. N-termini contribute to subcellular localization 540 ( Figure 4 and in (Lampard et al., 2014) ), to phenotypic output (Figure 4 ) and may mediate interactions 541 with downstream MPKs through their docking domains. In particular, we hypothesize that N7 has the 542 ability to bind different types of MPK. Throughout development, MKK7 inhibits stomatal development 543 by recruiting MPK3/6, but a yet unknown proliferative MPK mediates stomatal clustering at the FAMA 544 stage ( Figure 9A ). In the C-termini, Arabidopsis MKKs 1, 2, 4, 5 and 6 contain an extension that could be 545 equivalent to the MKKK-interacting domain for versatile docking (DVD) in human MEKs 1, 3, 4, 6 and 7 546 (Supplemental Figure 4) (Takekawa et al., 2005) . Arabidopsis MKK7, 8, 9, and 10, however, lack this 547 domain, making it unclear how they engage the appropriate MKKK. In fact, the addition of CDR5 to 548 MKK7 ED restricted this kinase's activity to an inhibitory output ( Figure 5C and G), suggesting that CDR5 549 interferes with MKK7 ED interactions. Upstream of the CDR, Loop A and B are two surface-exposed 550 modules in the CPR that may contribute to establishing interactions with other network components. In 551 our experiments, swapping loop A in MKK7 ED restricted its phenotypic output such that MKK7 ED -5A 552 only inhibited stomata formation ( Figure 5E , G).We propose then, that loop A promotes certain MKK-553 MPK interactions or, alternatively, restricts how MPKs contact MKKs. This hypothesis is supported by 554 sequence similarities between human MEKs that share the same downstream MAPKs (Keshet and Seger, 555 2010). For example, ERK kinases MEK1 and MEK2 have identical loop As, and p38 kinases MEK3 and 556 MEK6 differ at only one site (Supplemental Figure 4) . Interestingly, human MEK7, which can 557 phosphorylate both JNK and p38, shares some residues with MEK3 and MEK6 and others with the JNK 558 kinase MEK4. 559
The function of loop B seems to be associated to MKK-specific regulation. Our data shows that 560 loop B is required for robust MKK7 ED activity, but it prevents MKK5 DD -mediated inhibition at the FAMA 561 stage ( Figure 4F -G and 5F-G). Based on these phenotypes, we propose that loop B mediates interactions with different scaffolds (Figure 9) . A signal-promoting scaffold binds loop 7B and enforces MKK7 563 interactions with its cognate MKKK and MPK ( Figure 9A ). Such a scaffold would also explain why in 564 vivo activity of MKK7 ED was always stronger than that of MKK5 DD , even though in vitro assays showed 565 an opposite pattern. On the other hand, we predict that a distinct scaffold recruited by loop 5B prevents 566 MKK5 DD from inhibiting stomatal development at the FAMA stage (inhibitory scaffold) ( Figure 9B) . 567
This prediction could also partially explain the behavior of certain chimeras. . While the relevance of the first type is 586 quite intuitive, the second type is more controversial. The inhibitory scaffold EDR1 was identified in the 587 context of pathogen defense. Current hypotheses are that EDR1 provides a failsafe against inadvertently activating defense or cell death programs when other (not pathogen-induced) cues activate MAPK 589 signaling. EDR modulates MPK3 activity indirectly by interacting with MKK4/5 and regulating their 590 abundance (Zhao et al., 2014) . Interestingly, we observed in FAMA stage cells that MPK6 was only 591 inhibited when the upstream MKK was also inhibited. The clearest evidence that MKK5-MPK3/6 are 592 scaffolded in FAMA stage cells would be, of course, to identify the scaffold. We tested whether EDR1 593 worked to inhibit FAMA-stage expressed MKK5 DD , however we failed to see a loss of inhibition in edr1 594 (none seen in 20 independent T1s). EDR1 is a member of the large Raf-like MKKKs family (Ichimura et 595 al., 2002) and potentially any of the 48 members of this family (alone or in combination) could serve as a 596 stomatal scaffold. As testing the entire family in not technically feasible, we used stomatal lineage 597 expression data (Adrian et al., 2015) to identify two close homologues of EDR1 expressed at the FAMA 598 stage, MAP3K1 (At1g11850) and MAP3K5 (At4g24480). MAP3K1 and MAP3K5 mutants, however, 599
were indistinguishable from WT in their response to FAMA stage MKK5 DD expression (0/20 independent 600 T1s for each). Thus, the molecular identity of the stomatal scaffold remains of great future interest. ERK2, CDK2 and p38, and Pro-rich sequence (PRS, involved in binding the scaffold MP1) in MEK1 and 745 MEK2 were included in the alignment and cause an expansion of subdomain X. Secondary structure (2º 746 str.) information is overlaid in the alignment (red for α-helices and yellow for β-strands). Conserved α-747 helices and β-strands are labeled following convention (Hanks and Hunter, 1995; Knight et al., 2007) . 748
Due to CMGC insert and PRS, αG helix is located in two different regions of the alignment and was 749 named differently (residues underlined): αG1 for MmPKA, HsARK-1, RnCaMKI, RnERK2, HsCDK2 750 and Hsp38; and αG2 for HsMEK1/2 and AtMKK5/7. In green text, missing residues in crystal structures 751 from HsMEK1 and HsMEK2 which include the PRS. B, Table provides general 
